Gilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by Barry Investment Advisors LLC

Barry Investment Advisors LLC reduced its position in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 21.3% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,353 shares of the biopharmaceutical company’s stock after selling 907 shares during the period. Barry Investment Advisors […]

Related Keywords

United States ,Canada ,Merdad Parsey ,Complera Eviplera ,Tompkins Financial Corp ,Gilead Sciences Inc ,Exchange Commission ,Royal Bank ,Gilead Sciences Announces Dividend ,Rakuten Securities Inc ,Nasdaq ,News Ratings For Gilead Sciences Daily ,Gilead Sciences ,Barry Investment Advisors ,Fortitude Family Office ,Needham Company ,Gilead Sciences Company Profile ,Gilead Sciences Stock ,Barclays ,Maxim Group ,Quarter For Gilead Sciences ,Wealth Management Group ,Free Report ,Investment Advisors ,Financial Corp ,Family Office ,Rakuten Securities ,Get Free Report ,Visit Holdingschannel ,Gilead Sciences Daily ,